wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28550101-CEE86D15-91D9-4E18-9537-C682627F05D2
Q28550101-CEE86D15-91D9-4E18-9537-C682627F05D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28550101-CEE86D15-91D9-4E18-9537-C682627F05D2
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data
P2860
Q28550101-CEE86D15-91D9-4E18-9537-C682627F05D2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28550101-CEE86D15-91D9-4E18-9537-C682627F05D2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
34fb2c62b4b05c8a251ec76ce990a5061655d7c4
P2860
The cost-effectiveness, health benefits, and financial costs of new antiviral treatments for hepatitis C virus.